New Zealand Removes Hepatitis B and C from Resident Visa High-Cost Health Conditions
New Zealand has revised its resident visa health assessment rules, removing hepatitis B and C from the list of high-cost health conditions effective August 3, 2026. This change means applicants with these conditions will no longer automatically fail the health requirement but will be assessed individually. The decision follows a review showing treatment costs for these diseases have fallen below the significant-cost threshold. The update may benefit many prospective migrants, including Indian nationals, though health checks remain mandatory.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 46/100.
Outlets measured: businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 6 Aug, 07:38 am. Other outlets followed.